Parameter
| Biomarker | ADMA | Full name | Asymmetric dimethylarginine | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | C₈H₁₈N₄O₂ | Molecular Weight | 202.25 g/mol | Core Functional Dimensions | Renal function assessment、Early warning of complications |
| Disease | Chronic Kidney Disease (CKD) | Disease Subtypes | / | ||
| Organ | Kidney | Test Sample / Technology Platform | Blood, urine (protein detection) | ||
| Pathobiological Mechanisms | Inhibition of nitric oxide synthesis, leading to endothelial dysfunction, associated with cardiovascular risk | ||||
| Clinical Availability Status | Research verification stage | ||||
| Notes and Dynamics | It is an independent predictor of cardiovascular disease in CKD patients and is negatively correlated with endothelial dysfunction indicators ( such as brachial artery flow-mediated dilatation ). | ||||